FARINA, LUCIA
 Distribuzione geografica
Continente #
EU - Europa 2.839
NA - Nord America 2.663
AS - Asia 2.426
Continente sconosciuto - Info sul continente non disponibili 374
SA - Sud America 207
AF - Africa 33
OC - Oceania 4
Totale 8.546
Nazione #
US - Stati Uniti d'America 2.584
GB - Regno Unito 912
CN - Cina 726
SG - Singapore 724
DE - Germania 543
IT - Italia 378
SE - Svezia 281
RU - Federazione Russa 249
BD - Bangladesh 216
VN - Vietnam 161
HK - Hong Kong 160
IN - India 158
BR - Brasile 131
UA - Ucraina 100
FR - Francia 93
TR - Turchia 91
KR - Corea 70
IE - Irlanda 69
NL - Olanda 66
FI - Finlandia 53
CA - Canada 50
EU - Europa 42
JP - Giappone 38
CO - Colombia 33
ID - Indonesia 24
AR - Argentina 20
BE - Belgio 15
ES - Italia 15
PL - Polonia 14
CI - Costa d'Avorio 12
DK - Danimarca 11
MX - Messico 9
VE - Venezuela 9
MY - Malesia 8
PK - Pakistan 8
ZA - Sudafrica 8
AT - Austria 7
CZ - Repubblica Ceca 7
IQ - Iraq 6
PH - Filippine 5
RO - Romania 5
UZ - Uzbekistan 5
CL - Cile 4
BY - Bielorussia 3
EC - Ecuador 3
HU - Ungheria 3
JO - Giordania 3
NI - Nicaragua 3
PA - Panama 3
SA - Arabia Saudita 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CH - Svizzera 2
CR - Costa Rica 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
LB - Libano 2
LT - Lituania 2
MW - Malawi 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PY - Paraguay 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
JM - Giamaica 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 8.214
Città #
Southend 808
Singapore 462
Frankfurt am Main 343
Ashburn 321
Chandler 188
Beijing 181
San Jose 152
Hong Kong 151
Seattle 128
Milan 113
Council Bluffs 101
Ann Arbor 91
Wilmington 89
Princeton 87
Jacksonville 81
Santa Clara 76
Fairfield 72
Dublin 68
Dallas 66
Bengaluru 58
New York 55
Woodbridge 55
Los Angeles 54
Redmond 50
Somerville 50
Houston 47
Nanjing 46
Dearborn 43
Ho Chi Minh City 38
Des Moines 37
Hanoi 37
Buffalo 35
Lauterbourg 34
Andover 31
Boardman 30
Sakarya 30
Bogotá 29
Sunnyvale 29
Mountain View 28
Serra 27
Guangzhou 25
Hefei 25
Munich 25
Rome 25
Tokyo 24
Shanghai 23
Moscow 22
Berlin 21
Jinan 21
Cambridge 19
Nanchang 18
The Dalles 18
Toronto 18
Columbus 17
Shenyang 17
Dong Ket 16
São Paulo 16
Brussels 15
Phoenix 15
Cangzhou 13
Changsha 13
Hebei 13
Warsaw 13
Abidjan 12
Hangzhou 12
Tianjin 12
Naples 11
Shenzhen 11
Washington 11
Fuzhou 10
Zhengzhou 10
Hanover 9
Jakarta 9
Montreal 9
Turin 9
Turku 9
Verona 9
Bitonto 8
Charlotte 8
Chicago 8
Jiaxing 8
Kunming 8
Seoul 8
Auburn Hills 7
Da Nang 7
Eitensheim 7
Haikou 7
Helsinki 7
Istanbul 7
Mumbai 7
Palermo 7
San Diego 7
Taiyuan 7
Amsterdam 6
Dhaka 6
Haiphong 6
Hamburg 6
Madrid 6
Birmingham 5
Chennai 5
Totale 5.154
Nome #
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression 420
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 338
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia : early assessment can predict long-term outcome after reduced intensity allogeneic transplantation 311
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome 285
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma 282
The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era 262
Haemato-oncology and burnout : an Italian survey 247
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation 247
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen 230
Long-term outcome of ric-allo SCT for myeloma 228
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice 227
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas : pre-transplant disease status and histotype heavily influence outcome 224
Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates 214
Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed 199
Pre-emptive CD8-depleted donor lymphocyte infusions to overcome long-lasting immune deficiency after haploidentical stem cell transplantation with a reduced-intensity conditioning regimen 195
Current role of allogeneic stem cell transplantation in follicular lymphoma 192
Reduced intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed non-Hodgkin’s and Hodgkin’s lymphomas 189
Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor : an algorithm for the pre-emptive use of plerixafor 188
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 187
CD8-depleted donor lymphocyte infusions can boost immune reconstitution after haploidentical stem cell transplantation following reduced-intensity conditioning regimen 184
Molecular remission after reduced intensity allogeneic transplantation in chronic lymphocytic leukemia : a surrogate marker of the GVL effect that predicts survival and overcomes poor prognostic factor 182
Allogeneic transplantation for lymphoma : long-term outcome 174
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by pet scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma 174
Antibiotic prophylaxis before dental procedures can reduce ONJ incidence 172
Allogeneic stem cell transplantation after a RIC regimen prolongs the survival in patients with Hodgkin’s Lymphoma relapsed after high dose chemotherapy : a retrospective study based on donor availability 172
Allogeneic transplantation for Hodgkin's lymphoma 172
Improved Immune Reconstitution Following Pre-Emptive CD8-Depleted Donor Lymphocyte Infusions (DLIs) after Haploidentical Stem Cell Transplantation (SCT) Using a Reduced-Intensity Conditioning (RIC) Regimen 171
Pre-emptive CD8-depleted donor lymphocyte infusions to overcome long-lasting immune deficiency after haploidentical stem cell transplantation with a reduced intensity conditioning regimen 168
Prospective Validation of CAR-HEMATOTOX and a simplified version predict Survival in Patients with Large B-Cell Lymphoma treated with anti-CD19 CAR T-cells: data from CART-SIE study 165
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 165
CD8-depleted donor lymphocyte infusions can improve both T- and B-cell reconstitution after allogeneic stem cell transplantation from haploidentical family donors 164
Reduced-intensity allogeneic stem cell transplantation using related haploidentical donors for relapsed or refractory lymphomas : evidence of anti-tumour activity in poor prognosis disease 161
Efficacy and safety of cytarabine-based regimens for mobilization of peripheral blood stem cells in multiple myeloma 155
Long-term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemia 154
Current state of art for transplantation paradigms in peripheral T-cell lymphomas 149
Qualitative and Quantitative PCR Monitoring of MRD : Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia 148
Qualitative and Quantitative PCR Monitoring of MRD: Practical Implications of a Surrogate Marker for GVL Effect after RIC Allogeneic Transplantation in Relapsed Chronic Lymphocytic Leukemia. 143
Predicting failure of hematopoietic stem cell mobilization before it starts : the predicted poor mobilizer (pPM) score 143
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 142
A rare case of atypical chronic lymphocytic leukaemia presenting as nephrotic syndrome 141
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 139
Molecular methods used for the detection of autologous graft contamination in lymphoid disorders 131
Hematopoietic stem cell transplantation in peripheral T-cell lymphomas 129
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life Study 83
Totale 8.546
Categoria #
all - tutte 21.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022444 0 17 51 25 45 31 61 20 38 33 21 102
2022/2023653 82 70 75 63 79 136 2 21 55 9 47 14
2023/2024547 6 24 11 21 96 38 59 56 21 51 73 91
2024/20251.056 64 131 48 110 80 20 18 93 62 60 95 275
2025/20262.305 241 122 219 156 234 127 242 102 199 226 255 182
2026/2027323 176 147 0 0 0 0 0 0 0 0 0 0
Totale 8.546